Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Griffiths

Showing results (171-180 of 248) with videos related to

Pageof 25
Sort By:
The Lancet. Oncology|April 30, 2013
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trialThomas Crosby, Christopher N Hurt, Stephen Falk, et al.
Cellular Microbiology|March 8, 2014
Perforin-like protein PPLP2 permeabilizes the red blood cell membrane during egress of Plasmodium falciparum gametocytesChristine C Wirth, Svetlana Glushakova, Matthias Scheuermayer, et al.
Lancet (London, England)|March 10, 2009
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialDavid Sebag-Montefiore, Richard J Stephens, Robert Steele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC TrialFergus Macbeth, Simon Noble, Jessica Evans, et al.
Health Technology Assessment (Winchester, England)|May 27, 2021
Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCTDouglas Adamson, Jane Blazeby, Catharine Porter, et al.
The Journal of Clinical Investigation|February 23, 2016
Lymphatic endothelial cells are a replicative niche for Mycobacterium tuberculosisThomas R Lerner, Cristiane de Souza Carvalho-Wodarz, Urska Repnik, et al.
European Journal of Medicinal Chemistry|February 13, 2026
New antitubercular pretomanid analogues as potent payloads in polymeric micelles: Leveraging zebrafish assays to accelerate lead optimisationAndrew M Thompson, Nils-Jørgen K Dal, Francesca Boldrin, et al.
Journal of Cell Science|May 21, 2013
Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomesRaja Kalluru, Federico Fenaroli, David Westmoreland, et al.
The Lancet. Gastroenterology & Hepatology|February 21, 2021
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trialDouglas Adamson, Anthony Byrne, Catharine Porter, et al.
Ebiomedicine|July 25, 2020
Real-time imaging of polymersome nanoparticles in zebrafish embryos engrafted with melanoma cancer cells: Localization, toxicity and treatment analysisAgnese Kocere, Julien Resseguier, Jens Wohlmann, et al.
Pageof 25

Showing results (171-180 of 248) with videos related to

Sort By:
Pageof 25
The Lancet. Oncology|April 30, 2013
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trialThomas Crosby, Christopher N Hurt, Stephen Falk, et al.
Cellular Microbiology|March 8, 2014
Perforin-like protein PPLP2 permeabilizes the red blood cell membrane during egress of Plasmodium falciparum gametocytesChristine C Wirth, Svetlana Glushakova, Matthias Scheuermayer, et al.
Lancet (London, England)|March 10, 2009
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialDavid Sebag-Montefiore, Richard J Stephens, Robert Steele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC TrialFergus Macbeth, Simon Noble, Jessica Evans, et al.
Health Technology Assessment (Winchester, England)|May 27, 2021
Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCTDouglas Adamson, Jane Blazeby, Catharine Porter, et al.
The Journal of Clinical Investigation|February 23, 2016
Lymphatic endothelial cells are a replicative niche for Mycobacterium tuberculosisThomas R Lerner, Cristiane de Souza Carvalho-Wodarz, Urska Repnik, et al.
European Journal of Medicinal Chemistry|February 13, 2026
New antitubercular pretomanid analogues as potent payloads in polymeric micelles: Leveraging zebrafish assays to accelerate lead optimisationAndrew M Thompson, Nils-Jørgen K Dal, Francesca Boldrin, et al.
Journal of Cell Science|May 21, 2013
Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomesRaja Kalluru, Federico Fenaroli, David Westmoreland, et al.
The Lancet. Gastroenterology & Hepatology|February 21, 2021
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trialDouglas Adamson, Anthony Byrne, Catharine Porter, et al.
Ebiomedicine|July 25, 2020
Real-time imaging of polymersome nanoparticles in zebrafish embryos engrafted with melanoma cancer cells: Localization, toxicity and treatment analysisAgnese Kocere, Julien Resseguier, Jens Wohlmann, et al.
Pageof 25